Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Engineered Peptide Scrambling for Enhanced Drug Delivery to Resistant Breast Cancer Cells via Small Extracellular Vesicles

ACS Applied Bio Materials(2025)10.1021/acsabm.5c00582Source: DataRank Database

Engineered Peptide Scrambling for Enhanced Drug Delivery to Resistant Breast Cancer Cells via Small Extracellular Vesicles is a research paper published in ACS Applied Bio Materials (2025). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Download PDF

Cite:

Linked data & code

gen

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)Impact (FWCI 0.00)OA: hybridTopics (54)IDs (PubMed, PMC, OpenAlex)Annotations (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (10)

Joe Yuan,Najla Adel Saleh ORCID,Aimen Al‐Hilfi ORCID,Sadhana Kilangodi,Jake Sun

Live enrichment

PubMed:41321158 PMC:PMC12709616 OpenAlex:https://openalex.org/W4416847684

National Institute of Biomedical Imaging and Bioengineering

Grant: R01-EB030565

National Institute of Biomedical Imaging and Bioengineering

Grant: R01-EB031008

National Institute of Biomedical Imaging and Bioengineering

Grant: R21-EB033554

NIBIB NIH HHS

Grant: R01 EB031008

NIBIB NIH HHS

Grant: R21 EB033554

NIBIB NIH HHS

Grant: R01 EB030565

Michigan State University

FWCI

0.00

Citation Percentile

0.2%

hybridLicense: cc-by

journalhttps://pubs.acs.org/doi/pdf/10.1021/acsabm.5c00582?ref=article_openPDF

publisherhttps://pubs.acs.org/doi/pdf/10.1021/acsabm.5c00582?ref=article_openPDF

publisherhttps://pubs.acs.org/doi/pdf/10.1021/acsabm.5c00582

journalhttps://doi.org/10.1021/acsabm.5c00582

repositoryhttps://pubmed.ncbi.nlm.nih.gov/41321158

Fields of Study

Extracellular vesicles in diseaseNanoplatforms for cancer theranosticsAdvanced biosensing and bioanalysis techniquesHumansExtracellular VesiclesBreast NeoplasmsPeptidesDrug Delivery SystemsFemaleBiocompatible MaterialsAntineoplastic AgentsMethotrexateMaterials TestingDrug Resistance, NeoplasmDrug Screening Assays, AntitumorParticle SizeCell Line, TumorCell ProliferationCell SurvivalSurface Properties

MeSH Terms

Extracellular VesiclesAntineoplastic AgentsBiocompatible MaterialsBreast NeoplasmsCell SurvivalDrug Screening Assays, AntitumorFemaleHumansMaterials TestingMethotrexateParticle SizePeptidesSurface PropertiesDrug Delivery SystemsDrug Resistance, NeoplasmCell Line, TumorCell Proliferation

Keywords

PeptideDrug deliveryCytotoxicityTargeted drug deliveryCancer cellExtracellular vesiclesMicrovesiclesDrugPeptide libraryProdrugFluorescenceBioluminescenceCancerChemotherapyMethotrexate (Mtx)Extracellular VesicleTumor Homing Peptide

Engineered Peptide Scrambling for Enhanced Drug Delivery to Resistant Breast Cancer Cells via Small Extracellular Vesicles

FAIR Checklist

Authors (10)

Funding (7 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)